Nu Holdings reports Q1 2026 results on May 14 with a distinctive backdrop: its own founders have been net sellers, options traders are moving more defensive, and the stock has dropped 4.4% on the week.
The most striking pre-earnings signal comes from the executive suite. The co-founder and CEO, David Velez, along with co-founder Cristina Zingaretti and the CFO, all sold shares on April 23. Zingaretti made an additional pair of sales in late March totalling $4.4 million. Across the past 90 days, insiders have sold a net $5.7 million of stock. The trades carry low individual significance scores, and some may reflect pre-arranged plans, but the cluster of exec-level selling just weeks before the print is hard to ignore entirely.
Options positioning has also turned more guarded than usual. The put/call ratio has climbed to 0.68, its highest reading in the past year and roughly 1.6 standard deviations above the 20-day average of 0.60. That level of defensive hedging is elevated for a stock that normally sees call-dominant flow — it points to traders paying more for downside protection ahead of Wednesday's release.
Short interest, by contrast, offers little pressure either way. Short interest runs at 3.4% of the free float, barely changed on the month and drifting only modestly higher over the week. Borrow costs are minimal at 0.48%, and availability remains very loose — there is no sign of squeeze mechanics building. The ORTEX short score sits at 35, well below any alarm threshold.
The analyst debate centres on how quickly Nu can monetise its rapidly-growing customer base across Brazil, Mexico, and Colombia. CICC initiated coverage at Outperform with an $18 target in mid-April. UBS upgraded to Buy in mid-March, setting a $17.60 target — a meaningful shift after sitting at Neutral. The consensus mean target of nearly $20 implies about 44% upside to the current $13.80 share price. On fundamentals, the stock trades at a P/E around 14x and a price-to-book of roughly 4x — not cheap for a Latin American fintech, but less stretched than at prior peaks. Bears will point to currency exposure across Brazil and the FX sensitivity baked into reported earnings; bulls will argue that the growth runway — estimated revenues of $21 billion and net income approaching $4 billion on a forward basis — justifies the premium.
The historical earnings record adds an important caution. The last print, in late February, sent the stock down nearly 9% on the day and 9.3% over the following week — a pattern that may be shaping the current defensive options tilt. Thursday's report will test whether Nu can deliver on both the top-line growth story and the margin trajectory that bulls need to push the stock back toward analyst targets.
See the live data behind this article on ORTEX.
Open NU on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
